海南再有79种集中采购药品落地使用 25品种降幅超过八成
据《海南日报》从省医疗保障局获悉,海南省将於今日(10日)起正式执行国家组织第四批集中采购、「六省二区」省际联盟和「十一省」省际联盟药品集中采购等三个批次中选结果,涉及79个集中采购药品,三个批次价格平均降幅分别为44.56%、77.38%和71.45%,降幅超过80%的品种达到25个,涵盖抗癌药、平喘药、抗生素、滴眼液、糖尿病和心脑血管用药等多个常用药品种,百姓用药成本进一步降低。
据悉,海南省自2019年12月以来,已落地执行四个批次共计157种国家组织药品集中采购中选结果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.